nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Angina pectoris—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Salbutamol—Ill-defined disorder—Irinotecan—colon cancer	0.00274	0.00274	CcSEcCtD
Salbutamol—Bronchitis—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Salbutamol—Vertigo—Vincristine—colon cancer	0.00273	0.00273	CcSEcCtD
Salbutamol—Malaise—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Salbutamol—Vertigo—Irinotecan—colon cancer	0.00266	0.00266	CcSEcCtD
Salbutamol—Dysuria—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Salbutamol—Syncope—Irinotecan—colon cancer	0.00265	0.00265	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Salbutamol—Hypertension—Vincristine—colon cancer	0.00262	0.00262	CcSEcCtD
Salbutamol—Loss of consciousness—Irinotecan—colon cancer	0.0026	0.0026	CcSEcCtD
Salbutamol—Myalgia—Vincristine—colon cancer	0.00259	0.00259	CcSEcCtD
Salbutamol—Cough—Irinotecan—colon cancer	0.00258	0.00258	CcSEcCtD
Salbutamol—Hyperglycaemia—Capecitabine—colon cancer	0.00256	0.00256	CcSEcCtD
Salbutamol—Hypertension—Irinotecan—colon cancer	0.00255	0.00255	CcSEcCtD
Salbutamol—Discomfort—Irinotecan—colon cancer	0.00249	0.00249	CcSEcCtD
Salbutamol—Neuropathy peripheral—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Salbutamol—Anaphylactic shock—Vincristine—colon cancer	0.00248	0.00248	CcSEcCtD
Salbutamol—Oedema—Vincristine—colon cancer	0.00248	0.00248	CcSEcCtD
Salbutamol—Stomatitis—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Salbutamol—Jaundice—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Salbutamol—Infection—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Salbutamol—Conjunctivitis—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Salbutamol—Urinary tract infection—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Salbutamol—Nervous system disorder—Vincristine—colon cancer	0.00243	0.00243	CcSEcCtD
Salbutamol—Haematuria—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Salbutamol—Anaphylactic shock—Irinotecan—colon cancer	0.00241	0.00241	CcSEcCtD
Salbutamol—Oedema—Irinotecan—colon cancer	0.00241	0.00241	CcSEcCtD
Salbutamol—Chest pain—Fluorouracil—colon cancer	0.00241	0.00241	CcSEcCtD
Salbutamol—Myalgia—Fluorouracil—colon cancer	0.00241	0.00241	CcSEcCtD
Salbutamol—Infection—Irinotecan—colon cancer	0.0024	0.0024	CcSEcCtD
Salbutamol—Hyperhidrosis—Vincristine—colon cancer	0.0024	0.0024	CcSEcCtD
Salbutamol—Epistaxis—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Salbutamol—Discomfort—Fluorouracil—colon cancer	0.00238	0.00238	CcSEcCtD
Salbutamol—Shock—Irinotecan—colon cancer	0.00237	0.00237	CcSEcCtD
Salbutamol—Nervous system disorder—Irinotecan—colon cancer	0.00237	0.00237	CcSEcCtD
Salbutamol—Anorexia—Vincristine—colon cancer	0.00236	0.00236	CcSEcCtD
Salbutamol—Irritability—Methotrexate—colon cancer	0.00234	0.00234	CcSEcCtD
Salbutamol—Hyperhidrosis—Irinotecan—colon cancer	0.00233	0.00233	CcSEcCtD
Salbutamol—Mood swings—Methotrexate—colon cancer	0.00232	0.00232	CcSEcCtD
Salbutamol—Hypotension—Vincristine—colon cancer	0.00232	0.00232	CcSEcCtD
Salbutamol—Oedema—Fluorouracil—colon cancer	0.00231	0.00231	CcSEcCtD
Salbutamol—Anaphylactic shock—Fluorouracil—colon cancer	0.00231	0.00231	CcSEcCtD
Salbutamol—Anorexia—Irinotecan—colon cancer	0.0023	0.0023	CcSEcCtD
Salbutamol—Ataxia—Methotrexate—colon cancer	0.0023	0.0023	CcSEcCtD
Salbutamol—Infection—Fluorouracil—colon cancer	0.0023	0.0023	CcSEcCtD
Salbutamol—Haemoglobin—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Salbutamol—Rhinitis—Capecitabine—colon cancer	0.00228	0.00228	CcSEcCtD
Salbutamol—Haemorrhage—Capecitabine—colon cancer	0.00227	0.00227	CcSEcCtD
Salbutamol—Nervous system disorder—Fluorouracil—colon cancer	0.00227	0.00227	CcSEcCtD
Salbutamol—Hypoaesthesia—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00226	0.00226	CcSEcCtD
Salbutamol—Pharyngitis—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Salbutamol—Tachycardia—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Salbutamol—Hypotension—Irinotecan—colon cancer	0.00226	0.00226	CcSEcCtD
Salbutamol—Urinary tract disorder—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Salbutamol—Insomnia—Vincristine—colon cancer	0.00224	0.00224	CcSEcCtD
Salbutamol—Connective tissue disorder—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Salbutamol—Urethral disorder—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Salbutamol—Paraesthesia—Vincristine—colon cancer	0.00223	0.00223	CcSEcCtD
Salbutamol—Anorexia—Fluorouracil—colon cancer	0.0022	0.0022	CcSEcCtD
Salbutamol—Insomnia—Irinotecan—colon cancer	0.00218	0.00218	CcSEcCtD
Salbutamol—Paraesthesia—Irinotecan—colon cancer	0.00217	0.00217	CcSEcCtD
Salbutamol—Hypotension—Fluorouracil—colon cancer	0.00216	0.00216	CcSEcCtD
Salbutamol—Decreased appetite—Vincristine—colon cancer	0.00215	0.00215	CcSEcCtD
Salbutamol—Dyspnoea—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Salbutamol—Somnolence—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Vincristine—colon cancer	0.00214	0.00214	CcSEcCtD
Salbutamol—Fatigue—Vincristine—colon cancer	0.00214	0.00214	CcSEcCtD
Salbutamol—Dyspepsia—Irinotecan—colon cancer	0.00212	0.00212	CcSEcCtD
Salbutamol—Tinnitus—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Salbutamol—Pain—Vincristine—colon cancer	0.00212	0.00212	CcSEcCtD
Salbutamol—Constipation—Vincristine—colon cancer	0.00212	0.00212	CcSEcCtD
Salbutamol—Asthma—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Salbutamol—Flushing—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Salbutamol—Cardiac disorder—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00211	0.00211	CcSEcCtD
Salbutamol—Decreased appetite—Irinotecan—colon cancer	0.0021	0.0021	CcSEcCtD
Salbutamol—Insomnia—Fluorouracil—colon cancer	0.00209	0.00209	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Salbutamol—Fatigue—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Salbutamol—Paraesthesia—Fluorouracil—colon cancer	0.00208	0.00208	CcSEcCtD
Salbutamol—Pain—Irinotecan—colon cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Constipation—Irinotecan—colon cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Angiopathy—Capecitabine—colon cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Dyspnoea—Fluorouracil—colon cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Somnolence—Fluorouracil—colon cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Immune system disorder—Capecitabine—colon cancer	0.00205	0.00205	CcSEcCtD
Salbutamol—Mediastinal disorder—Capecitabine—colon cancer	0.00205	0.00205	CcSEcCtD
Salbutamol—Chills—Capecitabine—colon cancer	0.00204	0.00204	CcSEcCtD
Salbutamol—Dyspepsia—Fluorouracil—colon cancer	0.00204	0.00204	CcSEcCtD
Salbutamol—Arrhythmia—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Salbutamol—Gastrointestinal pain—Vincristine—colon cancer	0.00203	0.00203	CcSEcCtD
Salbutamol—Decreased appetite—Fluorouracil—colon cancer	0.00201	0.00201	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.002	0.002	CcSEcCtD
Salbutamol—Mental disorder—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Salbutamol—Feeling abnormal—Irinotecan—colon cancer	0.00199	0.00199	CcSEcCtD
Salbutamol—Malnutrition—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Salbutamol—Dysuria—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Salbutamol—Pain—Fluorouracil—colon cancer	0.00198	0.00198	CcSEcCtD
Salbutamol—Gastrointestinal pain—Irinotecan—colon cancer	0.00197	0.00197	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Salbutamol—Abdominal pain—Vincristine—colon cancer	0.00196	0.00196	CcSEcCtD
Salbutamol—Body temperature increased—Vincristine—colon cancer	0.00196	0.00196	CcSEcCtD
Salbutamol—Flatulence—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Salbutamol—Dysgeusia—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Salbutamol—Back pain—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Salbutamol—Abdominal pain—Irinotecan—colon cancer	0.00191	0.00191	CcSEcCtD
Salbutamol—Body temperature increased—Irinotecan—colon cancer	0.00191	0.00191	CcSEcCtD
Salbutamol—Feeling abnormal—Fluorouracil—colon cancer	0.00191	0.00191	CcSEcCtD
Salbutamol—Muscle spasms—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Salbutamol—Drowsiness—Methotrexate—colon cancer	0.00189	0.00189	CcSEcCtD
Salbutamol—Tremor—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Salbutamol—Stomatitis—Methotrexate—colon cancer	0.00184	0.00184	CcSEcCtD
Salbutamol—Ill-defined disorder—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Salbutamol—Urticaria—Fluorouracil—colon cancer	0.00184	0.00184	CcSEcCtD
Salbutamol—Conjunctivitis—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Salbutamol—Body temperature increased—Fluorouracil—colon cancer	0.00183	0.00183	CcSEcCtD
Salbutamol—Hypersensitivity—Vincristine—colon cancer	0.00183	0.00183	CcSEcCtD
Salbutamol—Sweating—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Salbutamol—Haematuria—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Salbutamol—Malaise—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Salbutamol—Epistaxis—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Salbutamol—Vertigo—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Salbutamol—Hypersensitivity—Irinotecan—colon cancer	0.00178	0.00178	CcSEcCtD
Salbutamol—Asthenia—Vincristine—colon cancer	0.00178	0.00178	CcSEcCtD
Salbutamol—Syncope—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Salbutamol—Palpitations—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Salbutamol—Loss of consciousness—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Salbutamol—Asthenia—Irinotecan—colon cancer	0.00173	0.00173	CcSEcCtD
Salbutamol—Cough—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Salbutamol—Hypertension—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Salbutamol—Hypersensitivity—Fluorouracil—colon cancer	0.0017	0.0017	CcSEcCtD
Salbutamol—Haemoglobin—Methotrexate—colon cancer	0.0017	0.0017	CcSEcCtD
Salbutamol—Diarrhoea—Vincristine—colon cancer	0.0017	0.0017	CcSEcCtD
Salbutamol—Haemorrhage—Methotrexate—colon cancer	0.00169	0.00169	CcSEcCtD
Salbutamol—Arthralgia—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Salbutamol—Chest pain—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Salbutamol—Myalgia—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Salbutamol—Pharyngitis—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Salbutamol—Anxiety—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Salbutamol—Urinary tract disorder—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Salbutamol—Discomfort—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Salbutamol—Urethral disorder—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Salbutamol—Diarrhoea—Irinotecan—colon cancer	0.00165	0.00165	CcSEcCtD
Salbutamol—Dry mouth—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Salbutamol—Dizziness—Vincristine—colon cancer	0.00164	0.00164	CcSEcCtD
Salbutamol—Pruritus—Fluorouracil—colon cancer	0.00164	0.00164	CcSEcCtD
Salbutamol—Oedema—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Salbutamol—Infection—Capecitabine—colon cancer	0.0016	0.0016	CcSEcCtD
Salbutamol—Dizziness—Irinotecan—colon cancer	0.0016	0.0016	CcSEcCtD
Salbutamol—Shock—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Salbutamol—Nervous system disorder—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Salbutamol—Diarrhoea—Fluorouracil—colon cancer	0.00158	0.00158	CcSEcCtD
Salbutamol—Tinnitus—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Salbutamol—Tachycardia—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Salbutamol—Vomiting—Vincristine—colon cancer	0.00158	0.00158	CcSEcCtD
Salbutamol—Cardiac disorder—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Salbutamol—Skin disorder—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Salbutamol—Rash—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Salbutamol—Hyperhidrosis—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Salbutamol—Dermatitis—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Salbutamol—Headache—Vincristine—colon cancer	0.00155	0.00155	CcSEcCtD
Salbutamol—Anorexia—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Salbutamol—Angiopathy—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Salbutamol—Vomiting—Irinotecan—colon cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Immune system disorder—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Dizziness—Fluorouracil—colon cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Mediastinal disorder—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Rash—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Salbutamol—Dermatitis—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Salbutamol—Chills—Methotrexate—colon cancer	0.00152	0.00152	CcSEcCtD
Salbutamol—Headache—Irinotecan—colon cancer	0.00151	0.00151	CcSEcCtD
Salbutamol—Hypotension—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Salbutamol—Mental disorder—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Malnutrition—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Salbutamol—Nausea—Vincristine—colon cancer	0.00147	0.00147	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Salbutamol—Vomiting—Fluorouracil—colon cancer	0.00147	0.00147	CcSEcCtD
Salbutamol—Insomnia—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Salbutamol—Rash—Fluorouracil—colon cancer	0.00146	0.00146	CcSEcCtD
Salbutamol—Dermatitis—Fluorouracil—colon cancer	0.00146	0.00146	CcSEcCtD
Salbutamol—Paraesthesia—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Salbutamol—Headache—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Salbutamol—Dysgeusia—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Salbutamol—Dyspnoea—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Salbutamol—Nausea—Irinotecan—colon cancer	0.00143	0.00143	CcSEcCtD
Salbutamol—Back pain—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Salbutamol—Dyspepsia—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Salbutamol—Decreased appetite—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Salbutamol—Fatigue—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Salbutamol—Pain—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Salbutamol—Constipation—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Salbutamol—Nausea—Fluorouracil—colon cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Ill-defined disorder—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Feeling abnormal—Capecitabine—colon cancer	0.00133	0.00133	CcSEcCtD
Salbutamol—Malaise—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Salbutamol—Vertigo—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Salbutamol—Gastrointestinal pain—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Salbutamol—Cough—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Salbutamol—Urticaria—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Salbutamol—Abdominal pain—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Salbutamol—Body temperature increased—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Salbutamol—Chest pain—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Salbutamol—Arthralgia—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Salbutamol—Myalgia—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Salbutamol—Discomfort—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Salbutamol—Anaphylactic shock—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Salbutamol—Infection—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Salbutamol—Hypersensitivity—Capecitabine—colon cancer	0.00119	0.00119	CcSEcCtD
Salbutamol—Nervous system disorder—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Salbutamol—Skin disorder—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Salbutamol—Hyperhidrosis—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Salbutamol—Asthenia—Capecitabine—colon cancer	0.00116	0.00116	CcSEcCtD
Salbutamol—Anorexia—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Salbutamol—Pruritus—Capecitabine—colon cancer	0.00114	0.00114	CcSEcCtD
Salbutamol—Hypotension—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Salbutamol—Diarrhoea—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Salbutamol—Insomnia—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Salbutamol—Paraesthesia—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Salbutamol—Dyspnoea—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Salbutamol—Somnolence—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Salbutamol—Dizziness—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Salbutamol—Dyspepsia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Salbutamol—Decreased appetite—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Fatigue—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Pain—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Salbutamol—Vomiting—Capecitabine—colon cancer	0.00103	0.00103	CcSEcCtD
Salbutamol—Rash—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Salbutamol—Dermatitis—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Salbutamol—Headache—Capecitabine—colon cancer	0.00101	0.00101	CcSEcCtD
Salbutamol—Feeling abnormal—Methotrexate—colon cancer	0.000991	0.000991	CcSEcCtD
Salbutamol—Gastrointestinal pain—Methotrexate—colon cancer	0.000983	0.000983	CcSEcCtD
Salbutamol—Nausea—Capecitabine—colon cancer	0.00096	0.00096	CcSEcCtD
Salbutamol—Urticaria—Methotrexate—colon cancer	0.000955	0.000955	CcSEcCtD
Salbutamol—Abdominal pain—Methotrexate—colon cancer	0.000951	0.000951	CcSEcCtD
Salbutamol—Body temperature increased—Methotrexate—colon cancer	0.000951	0.000951	CcSEcCtD
Salbutamol—Hypersensitivity—Methotrexate—colon cancer	0.000886	0.000886	CcSEcCtD
Salbutamol—Asthenia—Methotrexate—colon cancer	0.000863	0.000863	CcSEcCtD
Salbutamol—Pruritus—Methotrexate—colon cancer	0.000851	0.000851	CcSEcCtD
Salbutamol—Diarrhoea—Methotrexate—colon cancer	0.000823	0.000823	CcSEcCtD
Salbutamol—Dizziness—Methotrexate—colon cancer	0.000795	0.000795	CcSEcCtD
Salbutamol—Vomiting—Methotrexate—colon cancer	0.000765	0.000765	CcSEcCtD
Salbutamol—Rash—Methotrexate—colon cancer	0.000758	0.000758	CcSEcCtD
Salbutamol—Dermatitis—Methotrexate—colon cancer	0.000758	0.000758	CcSEcCtD
Salbutamol—Headache—Methotrexate—colon cancer	0.000753	0.000753	CcSEcCtD
Salbutamol—Nausea—Methotrexate—colon cancer	0.000714	0.000714	CcSEcCtD
